Non-motor symptoms (NMS) improvement is positively correlated with baseline NMS burden and improved quality of life in advanced Parkinson's disease patients treated with levodopa-carbidopa intestinal gel: a post-hoc analysis from the GLORIA registry

被引：0
|
作者：
Poewe, W. [1 ]
Bergmann, L. [2 ]
Antonini, A. [3 ]
Chaudhuri, K. R. [4 ,5 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] AbbVie Inc, N Chicago, IL USA
[3] Univ Padua, Dept Neurosci, Padua, Italy
[4] Kings Coll London, London, England
[5] Kings Coll Hosp London, London, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3072
引用
收藏
页码：518 / 519
页数：2
相关论文
共 50 条
  • [31] Long-term Motor and Non-Motor Symptom Benefits in Patients With Advanced Parkinsons Disease Treated With Levodopa-Carbidopa Intestinal Gel by Baseline Hoehn & Yahr Stage: Analysis of the DUOGLOBE Study
    Pontieri, Francesco
    Chaudhuri, K. Ray
    Aldred, Jason
    Bourgeois, Paul
    Davis, Thomas
    Cubo, Esther
    Anca-Herschkovitsch, Marieta
    Lansek, Robert
    Siddiqui, Mustafa
    Simu, Mihaela
    Bergmann, Lars
    Ladhani, Omar
    Gao, Tianming
    Standaert, David
    Kovacs, Norbert
    NEUROLOGY, 2022, 98 (18)
  • [32] E-DUO Study: Use of levodopa-carbidopa intestinal gel in Spanish advanced Parkinson's disease patients. Non-motor symptoms and clinical global impression subanalyses
    Parra, J. C.
    Santos, D.
    Catalan, M. J.
    Regidor, I.
    MOVEMENT DISORDERS, 2015, 30 : S175 - S175
  • [33] Effect of Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy on non-motor symptoms in patients with advance Parkinson's disease
    Vuletic, V.
    MOVEMENT DISORDERS, 2019, 34 : S669 - S669
  • [34] An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients
    Krueger, Rejko
    Lingor, Paul
    Doskas, Triantafyllos
    Henselmans, Johanna M. L.
    Danielsen, Erik H.
    de Fabregues, Oriol
    Stefani, Alessandro
    Sensken, Sven-Christian
    Parra, Juan Carlos
    Onuk, Koray
    Yegin, Ashley
    Antonini, Angelo
    ADVANCES IN THERAPY, 2017, 34 (07) : 1741 - 1752
  • [35] Correlation between non-motor symptoms and quality of life in Parkinson's disease: Results of a post-hoc analysis of the RECOVER study
    Friedman, J. H.
    Chaudhuri, K. R.
    Surmann, E.
    Ghys, L.
    Trenkwalder, C.
    MOVEMENT DISORDERS, 2011, 26 : S127 - S128
  • [36] Motor- and Non-motor Symptoms in Patients Treated with 24-hour Daily Levodopa-Carbidopa Intestinal Gel Infusion: Analysis of the COSMOS Observational Study
    Kovacs, N.
    Szasz, J.
    Vela-Desojo, L.
    Svenningsson, P.
    Femia, S.
    Parra, J. Carlos
    Fasano, A.
    MOVEMENT DISORDERS, 2020, 35 : S618 - S619
  • [37] Non-motor symptoms in advanced Parkinson's disease patients treated with levodopa/carbidopa intestinal gel, deep brain stimulation, or continuous subcutaneous apomorphine: A systematic literature review and pooled analysis
    Chaudhuri, K. R.
    Terasawa, E.
    Jalundhwala, Y.
    Macaulay, D.
    Ayyagari, R.
    Zhou, Z. Y.
    Marshall, T.
    Chatamra, K.
    Yucel, A.
    Sail, K.
    MOVEMENT DISORDERS, 2016, 31 : S133 - S133
  • [38] Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes
    Antonini, Angelo
    Yegin, Ashley
    Preda, Cornelia
    Bergmann, Lars
    Poewe, Werner
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 231 - 235
  • [39] Efficacy and Safety of Levodopa-Carbidopa Intestinal Gel in Patients with <10 Years of Parkinson's Disease - Interim Results from the GLORIA Long-term Registry
    Antonini, Angelo
    Chaudhuri, K. Ray
    Bergmann, Lars
    Yegin, Ashley
    Onuk, Koray
    Poewe, Werner
    ANNALS OF NEUROLOGY, 2015, 78 : S45 - S45
  • [40] Design and Baseline Characteristics of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson's Disease - INSIGHTS Study
    Chung, S.
    Garriga, M.
    Ceravolo, M.
    Tambasco, N.
    Robieson, W.
    Facheris, M.
    Sanchez-Solino, O.
    Barbato, L.
    MOVEMENT DISORDERS, 2019, 34 : S36 - S36
12345